Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers, Ro and LifeMD to sell branded versions of ...

Shares of WW International, formerly WeightWatchers ( NASDAQ: WW ), jumped on Tuesday after it announced a partnership with ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

Pfizer ( PFE) reported mixed first quarter earnings Tuesday, as the company struggles to gain investor interest in its ...

The Dow and S&P 500 look to notch a sixth day of gains as investors await more trade news and an easing of tariffs on ...

Donald Trump underestimates the difficulty of producing in America—and how his own policies will make it harder ...

In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week ...

Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...

WeightWatchers (NASDAQ: WW) ("WeightWatchers,” "WW,” or the "Company”), the global leader in science-backed weight management, today announced a pharmacy integration with Eli Lilly and Company's ...